Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa may be more severe in people with Mediterranean fever gene mutations.

Frontal fibrosing alopecia is a complex condition with no definitive treatment.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Multiple perifollicular fibromas may actually be unrecognized cases of Birt-Hogg-Dubé syndrome.

Systemic lupus erythematosus is an autoimmune disease causing diverse symptoms and major organ involvement.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Managing myasthenia gravis is crucial and does not worsen primary Sjögren's syndrome.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Satoyoshi syndrome is likely an autoimmune disease.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

Early diagnosis and treatment are crucial for managing Folliculotropic Mycosis Fungoides on the scalp.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.